339 related articles for article (PubMed ID: 34645377)
1. Moxifloxacin Derivatives with Potential Antibacterial Activity against Methicillin- Resistant Staphylococcus Aureus (MRSA).
Chen R; Xue H; Xu Y; Ma T; Liu Y; Zhang J; Shi X; Guo D
Curr Top Med Chem; 2021; 21(27):2474-2482. PubMed ID: 34645377
[TBL] [Abstract][Full Text] [Related]
2. Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2.
Morrow BJ; Abbanat D; Baum EZ; Crespo-Carbone SM; Davies TA; He W; Shang W; Queenan AM; Lynch AS
Antimicrob Agents Chemother; 2011 Dec; 55(12):5512-21. PubMed ID: 21911562
[TBL] [Abstract][Full Text] [Related]
3.
Mohamed NM; Zakaria AS; Edward EA; Abdel-Bary A
Pol J Microbiol; 2019; 68(1):59-69. PubMed ID: 31050254
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
[TBL] [Abstract][Full Text] [Related]
6. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
Xu Z
Eur J Med Chem; 2020 Nov; 206():112686. PubMed ID: 32795773
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).
Kim HY; Wiles JA; Wang Q; Pais GC; Lucien E; Hashimoto A; Nelson DM; Thanassi JA; Podos SD; Deshpande M; Pucci MJ; Bradbury BJ
J Med Chem; 2011 May; 54(9):3268-82. PubMed ID: 21425851
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
Yan X; Lv Z; Wen J; Zhao S; Xu Z
Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
Morrow BJ; He W; Amsler KM; Foleno BD; Macielag MJ; Lynch AS; Bush K
Antimicrob Agents Chemother; 2010 May; 54(5):1955-64. PubMed ID: 20176911
[TBL] [Abstract][Full Text] [Related]
10. 1,2,4-Triazole hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus.
Ge X; Xu Z
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000223. PubMed ID: 32985011
[TBL] [Abstract][Full Text] [Related]
11. Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities.
Okamura S; Nishiyama E; Yamazaki T; Otsuka N; Taniguchi S; Ogawa W; Hatano T; Tsuchiya T; Kuroda T
Biochim Biophys Acta; 2015 Jun; 1850(6):1245-52. PubMed ID: 25731981
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus.
Lee SY; Fan HW; Sutherland C; DeRyke AC; Nicolau DP
Drugs R D; 2007; 8(2):69-77. PubMed ID: 17324004
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
[TBL] [Abstract][Full Text] [Related]
15. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
Dalhoff A; Schubert S
Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
[TBL] [Abstract][Full Text] [Related]
16. Evolution and Antibacterial Evaluation of 8-Hydroxy-cycloberberine Derivatives as a Novel Family of Antibacterial Agents Against MRSA.
Yang YS; Wei W; Hu XX; Tang S; Pang J; You XF; Fan TY; Wang YX; Song DQ
Molecules; 2019 Mar; 24(5):. PubMed ID: 30862066
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1H-pyrazol-4- yl)methylene)-2-thioxothiazolidin-4-one Derivatives.
Wei ZY; Liu JC; Zhang W; Li YR; Li C; Zheng CJ; Piao HR
Med Chem; 2016; 12(8):751-759. PubMed ID: 27550428
[TBL] [Abstract][Full Text] [Related]
18. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
Hesje CK; Borsos SD; Blondeau JM
J Ocul Pharmacol Ther; 2009 Aug; 25(4):329-34. PubMed ID: 19650708
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.
Valenzuela MV; Domenech M; Mateos-Martínez P; González-Camacho F; de la Campa AG; García MT
PLoS One; 2020; 15(11):e0241780. PubMed ID: 33141832
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
